Insidermedicine Daily News (Video)
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured ...
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured by Google News and The News Room. April 25, 2007 Patients with HIV who are treated with protease inhibitors have an increased risk of heart attack, according to a study published in the New England Journal of Medicine. Combination antiretroviral therapy has had a dramatic effect in reducing illness and death associated with the HIV virus, however an earlier study showed that the risk of heart attacks increased by 17% with every year a patient spent on antiretroviral. It isn’t known, though, whether all antiretroviral drugs carry this risk. The assessment of the role of any specific drug is difficult because patients with HIV usually receive a combination of drugs, and often switch regimens because of the availability of newer substances, adverse events, or drug regimen failure. Previous studies have shown a relationship between the use of protease inhibitors, a class of antiretroviral drug, and cardiovascular disease, but there is little information on the risks associated with another class of antiretroviral therapy called nonnucleoside reverse-transcriptase inhibitors. In this study, more than 23,000 patients infected with the HIV virus were assessed to determine the incidence of heart attack and the association between heart attack and exposure to protease inhibitors or nonnucleoside reverse-transcriptase inhibitors. Confirming the earlier results, the researchers found the risk of having a heart attack increased by 16% per year of exposure to protease inhibitors alone, which is equal to twice the risk over five years. Not such effect was observed with nonnucleoside reverse-transcriptase inhibitors. It is thought that protease inhibitors raise the level of blood lipid, thereby increasing the risk of cardiovascular disease and heart attack. Patients treated with protease inhibitors should have their cholesterol and blood pressure levels monitored, and take steps to reduce their lifestyle-related risk factors. This includes maintaining a healthy weight, eating a low-fat diet rich in fruits in vegetables, and getting regular exercise. Reporting for Insidermedicine, I'm Dr. Susan Sharma.
Show all Visit Show Website http://www.insidermedicine.caRecently Aired
-
HD
Mercury levels in fish may be overstated
(September 30, 2013 - Insidermedicine) From the UK - According ...
(September 30, 2013 - Insidermedicine) From the UK - According to research published in Environmental Health Perspectives, mercury levels in fish may not be as concerning as previously thought. Researchers studied over 100 food and drink items that were consumed by nearly 5,000 pregnant women. Results showed that these items together accounted for less that 17% of mercury levels in the body. The new report found that fish, specifically, accounts for only 7% of mercury levels in the body.
-
HD
Leisure time activity can keep blood pressure normal
(September 30, 2013 - Insidermedicine) From China - Getting physical ...
(September 30, 2013 - Insidermedicine) From China - Getting physical activity in your leisure time may keep your blood pressure healthy, according to a report published in Hypertension. Researchers conducted a meta-analysis comprised of 13 studies and over 130,000 individuals from the US, Europe and Asia. Follow-up ranged from 2-45 years. Results showed that those who exercised over 4 hours per week in their leisure time were 19% reduced risk of high blood pressure, wen compared to those who exercised less than one hour per week. Those who had 1-3 hours of exercise per week in their leisure time were at 11% reduced risk.
-
HD
Children's ER visits for concussions increasing dramatically
(September 30, 2013 - Insidermedicine) From Cincinnati - A new ...
(September 30, 2013 - Insidermedicine) From Cincinnati - A new report published in Pediatrics finds that children's emergency room visits for concussions are increasing. Ressearchers studied nearly 4,000 children and adolescents who presented to the hospital with a sports-related traumatic brain injury over a 9 year period. Results showed that, from 2002-2011, these visits increased by 92%
-
HD
Report questions whether fish, nuts truly benefit thinking skills
(September 26, 2013 - Insidermedicine) From Iowa - A new ...
(September 26, 2013 - Insidermedicine) From Iowa - A new report published in Neurology questions whether omega-3 fatty acids truly benefit cognitive skills. Researchers studied over 2,000 women between the ages of 65 and 80. Participants underwent annual thinking and memory skills testing and were followed for an average of 6 years. Blood tests measures participants omega-3 levels prior to the start of the study. Results showed that there was no difference in thinking skills tests between women with high and low levels of omega-3s in their blood. Results also showed no difference between these two women in regards to the thinking skill decline.
-
HD
Assessing the mortality among central retinal vein occlusion patients
(September 25, 2013 - Insidermedicine) From Denmark - A new ...
(September 25, 2013 - Insidermedicine) From Denmark - A new report published in Ophthalmology assess mortality in patients with central retinal vein occlusion. Researchers reviewed data from national registries to compare mortality rates among CRVO patients to a cohort of matched controls. Results showed that mortality was indeed higher among the CRVO patients. This higher mortality rate was statistically attributed to cardiovascular conditions and diabetes.
-
HD
Psoriasis drug may have potential in treating type 1 diabetes
(September 25, 2013 - Insidermedicine) From Indiana - A new ...
(September 25, 2013 - Insidermedicine) From Indiana - A new report published the Lancet Diabetes and Endocrinology finds that a psoriasis drug may have potential in treating type 1 diabetes. Researchers studied 49 newly diagnosed type 1 diabetics from 14 different clinical centres in the US. 33 of the participants received the psoriasis drug, Alefacept, every week for 12 weeks, followed by a break of 12 weeks, and then another 12 week session of injections. The 16 remaining participants received placebo with the same schedule. Researchers then measured how well participants pancreas could secrete insulin two hours after eating food. Results showed that those who received the diabetes drug had no increase in their insulin levels after eating, while those in the placebo group saw their levels increase.
-
HD
40 million cases of poor care in hospitals worldwide
(September 23, 2013 - Insidermedicine) From Boston - According to ...
(September 23, 2013 - Insidermedicine) From Boston - According to a report published in the BMJ, there are over 40 million cases of poor hospital care every year worldwide. Researchers reviewed 4000 articles published from 1976 and after, all of which examined poor medical care around the world. There were seven key makers of poor medical care--UTIs from catheters, bloodstream infections from catheters, pneumonia acquired in hospital, blood clots, falls and bed sores. The most common form of poor care involved medicines in high-income countries, which were found to occur in 5% of all hospital visits, while blood clots were most common in low and middle income countries. Researchers found that for every 100 hospital admissions, there were 14.2 cases of poor care in high income countries, and 12.7 in low and middle income countries. These cases resulted in over 40 million adverse events per year
-
HD
Vitamin B supplements may reduce risk of stroke
(September 20, 2013 - Insidermedicine) From China - A new ...
(September 20, 2013 - Insidermedicine) From China - A new report published in Neurology finds that vitamin B supplements may reduce risk of stroke. Researchers conducted a meta-analysis comprised of 14 clinical trials and over 54,000 participants. All of these studies examined B vitamin use to placebo or low-dose B vitamin. Participants were followed for at least 6 months. Results showed that taking B vitamins reduced risk of stroke by 7%. However, supplements did not appear to reduce the severity of stroke or the risk of dying from it.
-
HD
Regular colonoscopy could prevent 40% of colorectal cancers
(September 20, 2013 - Insidermedicine) From Boston - Screening with ...
(September 20, 2013 - Insidermedicine) From Boston - Screening with colonoscopy every 10 years could prevent nearly half of all colorectal cancers, according to a report published in the New England Journal of Medicine. Researchers studied data on nearly 90,000 participants taking part in two long-term studies. Participants submitted questionnaires every two years from 1988 to 2008. Results showed that both colonoscopy and sigmoidoscopy reduced risk of getting colorectal cancer or dying from it. Researchers estimate that if people underwent colonoscopy every 10 years, 40% of all colorectal cancers would be prevented.
-
HD
Fewer MRSA infections in US in 2011
(September 17, 2013 - Insidermedicine) From Atlanta - There were ...
(September 17, 2013 - Insidermedicine) From Atlanta - There were fewer MRSA infections in the US in 2011, according to a report published in JAMA Internal Medicine. Researchers from the CDC reviewed cases of the antibiotic-resistant infection over the past 6 years. Results showed that there were just over 80,000 MRSA infections in 2011, 48,000 of which were health care-associated community-onset infections and 14,000 that were hospital-onset infections. Compared to 2005, the national incidence rates have decreased by 27.7% for health care-associated community-onset infections, and 54.2% for hospital-onset infections.
